Commitments and Contingencies - Additional Information (Details) $ in Thousands										1 Months Ended	3 Months Ended
	May 02, 2024	Apr. 30, 2024 USD ($) $ / twinPack	Feb. 28, 2024	Dec. 18, 2023 USD ($)	May 31, 2023 case	Feb. 28, 2023 USD ($)	Jun. 10, 2020 state action	Mar. 13, 2015 medication	Nov. 06, 2014 representative	Dec. 31, 2023 USD ($) case state	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	May 15, 2023	Nov. 01, 2019 state	May 10, 2019 state
Loss Contingencies [Line Items]
(Credit) charges related to legal matters, net											$ (94,359)	$ 436
Liabilities for legal matters - long term										$ 316	85,479
Opana ER® antitrust litigation
Loss Contingencies [Line Items]
(Credit) charges related to legal matters, net												$ 436
Loss contingency accrual										$ 50,000	$ 265,000
Litigation settlement, interest rate											3.00%
United States Department of Justice Investigations
Loss Contingencies [Line Items]
Number of sales representatives | representative									1
Number of generic prescription medications | medication								4
Percentage Of Prescribed Label													1.00%
Generic Digoxin and Doxycycline Antitrust Litigation
Loss Contingencies [Line Items]
Number of states, filed civil lawsuit | state							46								43
Loss contingency civil lawsuit filed number of additional states | state														9
Number of actions | action							2
Civil prescription opioid litigation
Loss Contingencies [Line Items]
(Credit) charges related to legal matters, net											$ (94,400)
Number of cases filed | case										900
Number of states with cases | state										7
Number of claims dismissed | case					2
Liabilities for legal matters - long term										$ 300	85,500
Estimated litigation liability										$ 21,500	$ 115,600
Civil prescription opioid litigation | Subsequent Event
Loss Contingencies [Line Items]
Litigation settlement agreement terms		10 years
Civil prescription opioid litigation | Litigation Settlement, Option One | Subsequent Event
Loss Contingencies [Line Items]
Litigation settlement amount		$ 92,500
Litigation settlement, product supply amount		$ 180,000
Litigation settlement, product supply price (in USD per twin pack) | $ / twinPack		125
Civil prescription opioid litigation | Litigation Settlement, Option One | Subsequent Event | Maximum
Loss Contingencies [Line Items]
Litigation settlement amount		$ 137,500
Civil prescription opioid litigation | Litigation Settlement, Option Two | Subsequent Event
Loss Contingencies [Line Items]
Litigation settlement agreement terms		4 years
Litigation settlement amount		$ 45,000
Litigation settlement, percentage of product value		25.00%
Ranitidine Litigation
Loss Contingencies [Line Items]
Number of states with cases | state										5
Metformin Litigation | Litigation Settlement, Option One | Subsequent Event
Loss Contingencies [Line Items]
Deadline period for defendants	3 days
Metformin Litigation | Litigation Settlement, Option Two | Subsequent Event
Loss Contingencies [Line Items]
Deadline period for defendants	30 days
Xyrem® (Sodium Oxybate) Antitrust Litigation
Loss Contingencies [Line Items]
Litigation settlement amount				$ 4,000		$ 1,900
Litigation settlement expense										$ 3,000
Estimated litigation liability										$ 2,000
UFCW Local 1500 Welfare Fund v. Takeda Pharmaceuticals U.S.A., Inc.
Loss Contingencies [Line Items]
Deadline period for defendants			45 days